Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study

The Lancet

Volumn 388, Issue 10048, 2016, Pages 983-993

  O'Connell, Philip J ^b   Zhang, Weijia ^a   Menon, Madhav C ^a   Yi, Zhengzi ^a   Schröppel, Bernd ^a   Gallon, Lorenzo ^d   Luan, Yi ^a   Rosales, Ivy A ^e   Ge, Yongchao ^a   Losic, Bojan ^a   Xi, Caixia ^a   Woytovich, Christopher ^a   Keung, Karen L ^a   Wei, Chengguo ^a   Greene, Ilana ^a   Overbey, Jessica ^a   Bagiella, Emilia ^a   Najafian, Nader ^f   Samaniego, Milagros ^g   Djamali, Arjang ^h   Alexander, Stephen I ^c   Nankivell, Brian J ^b   Chapman, Jeremy R ^b   Smith, Rex Neal ^e   Colvin, Robert ^e   Murphy, Barbara ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

^d NORTHWESTERN UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; ADVERSE EFFECTS; BIOPSY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; FIBROSIS; GENE EXPRESSION PROFILING; GENETIC SCREENING; GENETICS; GRAFT REJECTION; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATHOLOGY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FIBROSIS; GENE EXPRESSION PROFILING; GENETIC TESTING; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 84979581708     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30826-1     Document Type: Article

References (26)

1. 1 Matas, AJ, Smith, JM, Skeans, MA, et al. OPTN/SRTR 2013 annual data report: kidney. Am J Transplant 15:suppl 2 (2015), 1–34.
2. 2 Meier-Kriesche, HU, Schold, JD, Srinivas, TR, Kaplan, B, Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4 (2004), 378–383.
3. 3 Wolfe, RA, Roys, EC, Merion, RM, Trends in organ donation and transplantation in the United States, 1999–2008. Am J Transplant 10 (2010), 961–972.
4. 4 Nankivell, BJ, Borrows, RJ, Fung, CL, O'Connell, PJ, Allen, RD, Chapman, JR, The natural history of chronic allograft nephropathy. N Engl J Med 349 (2003), 2326–2333.
5. 5 Yilmaz, S, McLaughlin, K, Paavonen, T, et al. Clinical predictors of renal allograft histopathology: a comparative study of single-lesion histology versus a composite, quantitative scoring system. Transplantation 83 (2007), 671–676.
6. 6 Yilmaz, S, Tomlanovich, S, Mathew, T, et al. Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies. J Am Soc Nephrol 14 (2003), 773–779.
7. 7 Baboolal, K, Jones, GA, Janezic, A, Griffiths, DR, Jurewicz, WA, Molecular and structural consequences of early renal allograft injury. Kidney Int 61 (2002), 686–696.
8. 8 Solez, K, Colvin, RB, Racusen, LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8 (2008), 753–760.
9. 9 Isoniemi, H, Taskinen, E, Hayry, P, Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 58 (1994), 1195–1198.
10. 10 Einecke, G, Reeve, J, Sis, B, et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 120 (2010), 1862–1872.
11. 11 Naesens, M, Khatri, P, Li, L, et al. Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int 80 (2011), 1364–1376.
12. 12 Levey, AS, Bosch, JP, Lewis, JB, Greene, T, Rogers, N, Roth, D, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999), 461–470.
13. 13 Cosio, FG, Grande, JP, Wadei, H, Larson, TS, Griffin, MD, Stegall, MD, Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 5 (2005), 2464–2472.
14. 14 Stegall, MD, Park, WD, Larson, TS, et al. The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant 11 (2011), 698–707.
15. 15 Mannon, RB, Matas, AJ, Grande, J, et al. Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant 10 (2010), 2066–2073.
16. 16 Rockey, DC, Bell, PD, Hill, JA, Fibrosis—a common pathway to organ injury and failure. N Engl J Med 372 (2015), 1138–1149.
17. 17 Hayry, P, Paavonen, T, Taskinen, E, et al. Protocol core needle biopsy and histological chronic allograft damage index as surrogate endpoint for long-term graft survival. Transplant Proc 36 (2004), 89–91.
18. 18 El-Zoghby, ZM, Stegall, MD, Lager, DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 9 (2009), 527–535.
19. 19 Dai, C, Liu, Y, Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 15 (2004), 1402–1412.
20. 20 Majidi, M, Gutkind, JS, Lichy, JH, Deletion of the COOH terminus converts the ST5 p70 protein from an inhibitor of RAS signaling to an activator with transforming activity in NIH-3T3 cells. J Biol Chem 275 (2000), 6560–6565.
21. 21 Sasaki, A, Taketomi, T, Kato, R, et al. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat Cell Biol 5 (2003), 427–432.
22. 22 Lee, SH, Schloss, DJ, Jarvis, L, Krasnow, MA, Swain, JL, Inhibition of angiogenesis by a mouse sprouty protein. J Biol Chem 276 (2001), 4128–4133.
23. 23 Thum, T, Gross, C, Fiedler, J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456 (2008), 980–984.
24. 24 Tan, HB, Feng, Y, Liu, M, Wu, YC, Protective effects of FR167653 on chronic allograft nephropathy by inhibiting p38 MAPK in rats. Transplant Proc 40 (2008), 1685–1689.
25. 25 Wang, S, Jiang, J, Guan, Q, et al. Reduction of chronic allograft nephropathy by inhibition of extracellular signal-regulated kinase 1 and 2 signaling. Am J Physiol Renal Physiol 295 (2008), F672–F679.
26. 26 Azuma, H, Takahara, S, Matsumoto, K, et al. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 12 (2001), 1280–1292.